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(Eingegangen am 23. November 1970)
Current methods for estimating 5'-nucleotidase activity in human serum are critically discussed. The requirements for specificity in the
assay procedure are re-emphasised, special consideration being given to the absolute concentrations as well as the molar ratios of true and
alternative substrates. Substrate-inhibition, described in a previous Report is believed to be due to a non-linear relationship between
AMP concentration and optical density above 0.1 mM.
Die gegenwärtig gebrauchten Methoden zur Bestimmung der 5'-Nucleotidaseaktivität von menschlichem Serum werden kritisch be-
sprochen. Die Erfordernisse für die Spezifität des Bestimmungsverfahrens werden nachdrücklich hervorgehoben; besondere Überle-
gungen werden sowohl hinsichtlich der absoluten Konzentrationen als auch der molaren Verhältnisse von echten und alternativen Sub-
straten angestellt. Es ist anzunehmen, daß die Substrathemmung, die in einem früheren Bericht beschrieben wurde, von einem nicht-
linearen Verhältnis zwischen AMP-Konzentration und optischer Dichte oberhalb 0,1 mM abhängt.
In the past three years, we have described four methods
for the determination of 5'-nucleotidase (EC 3.1.3.5) in
human serum. The first is based upon magnesium acti-
vation (1). In two further reports, the S'-nucleotidase
was coupled with adenosine deaminase (EC 3.5.4.4) and
rate measurements were made at 265 nm (2) and at
340 nm (3). Finally, in a coupled reaction with ade-
nosine deaminase the BERTHELOT reaction was used
for the colorimetric measurement of the ammonia
produced (4). The last three techniques take advantage
of a high concentration of /?-glycerophosphate to
suppress hydrolysis of 5'-AMP by non-specific alkaline
phosphatase (5, 6). Concurrently, and in a number of
independent publications, a colorimetric method similar
to that of reference (4) has been presented by PERSIJN,
VAN DER SLIK, and their collaborators (7—10). The
last of these papers (10) contains a number of statements
which we consider to be in need of clarification. We
shall attempt to summarise the requirements for spe-
cificity in the determination of S'-nucleotidase activity.
Requirements for specificity
Substrate Concentration
Table 1 of reference (10) draws attention to the small
substrate concentrations used in spectrophotometric
assays relative to those used in colorimetric assays.
Our spectrophotometric assay (2) employs only 20 /
of serum in place of 100 (7) and the reaction is
monitored over 20 min. instead of 60min. (7), so
Tab. 1
Change in absorbance at 265 nm on incubating 20 U adenosine dea-
minase (Boehringer Corporation (London) Ltd,, Cat. No. 15069
EAAT) with 5'-AMP under conditions of BELFIELD and GOLDBERG (2)
for two hours in presence and absence of 0-glycerophosphate
adenosine
deaminase
/9-glycerophosphate
present absent
Lot 7170103
Lot 7220203
+0.006
0.000
—0.019
—0.016
that in the course of the assay, the method in reference
(7) consumes fifteen times more substrate than our
spectrophotometric method.
However, this in no way justifies the excessively high
substrate concentration (5 mn) used by these authors
since their own data (Fig. 3 of reference 10) show that
1 mM AMP is more than sufficient to sustain optimal
activity. Their complaint that optimal substrate con-
centration cannot be evaluated by the spectrophoto-
metric assay is surprising, since we have already pub-
lished a value for Km of S'-nucleotidase based upon
this assay (4). We have repeated this determination in
quadruplicate at five concentrations of AMP, and by
application of a computerised statistical analysis of the
data (11) derived a value of 9.82 ^ moles/litre (Standard
Error 1.15 /onoles) which is in good agreement with the
figure of 11 /jmoles/litre obtained by LEYBOLD and
colleagues (12, 13). This means that our substrate
concentration (0.1 ) theoretically supports 91% of
Vmax, and in practise this figure is closer to 97% (12).
Reference (10) cites a personal communication by one
of us (D. M. G.) to the effect that substrate inhibition
takes place above 0.12 mM AMP. This statement has
never been made by us; on the contrary, we have
published substrate-velocity curves (3) showing under
somewhat different reaction conditions a plateau in
S'-nucleotidase activity between 0.167 mM and 0.5 mM
provided that full suppression of non-specific alkaline
phosphatase is achieved (Fig. 1). LEYBOLD and col-
leagues (12, 13) claimed that such substrate inhibition
did in fact occur, but they were working at optical
densities greater than 2.7. AMP and inosine solutions
obey the BEER-LAMBERT Law at 265 nm and pH 7.9
to O. D. 1.9; beyond this, the relationship is non-
linear, and complex calibration curves using both
AMP and inosine are needed to convert O. D. changes
to the actual amount of substrate consumed. It is
probable that this necessity was not realised by LEYBOLD
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Fig. l
Hydrolysis by human serum of 5'-AMP measured by coupled kinetic
assay at 340 n m (3) with increasing concentrations. of 5'-AMP. The
ratio of j9-glycerophosphate to 5'-AMP is maintained at 15:1 (o)
and at 150:1(·)· Alkaline phosphatase activity of serum was 102
King Units per 100 ml (19).
and colleagues, leading to a progressive underestimate
of enzyme' activity as substrate, and therefore, Ε2β5
was increased.
Alternative Substrate Concentration
In our original description of the phenomenon of
enzyme diversion (5), and subsequently (6, 14), we
have emphasised the importance of a high molar ratio
of the substrate for non-specific phosphatase relative
to that of the specific phosphatase being measured.
This ratio has never been less than 100:1 for any of
the S'-nucleotidase methods proposed by us. Yet the
ratio of phenyl phosphate to AMP is only 8:5 in re-
ferences (9, 10). This ratio is much too low for adequate
suppression of alkaline phosphatase activity (Fig. 2).
It is clear from Figs. 1 and 2 of reference (9) that in-
creasing suppression of serum alkaline phosphatase
takes place when the phenyl phosphate concentration
is increased from 8 HIM (the concentration used by
these authors in their standard procedure ) to 25 mM.
A further contribution towards improving specificity
would be achieved, by lowering the AMP concentration
to 1 mM; this would also reduce the value of the bknk
due to the presence of free adenosine in the substrate,
which can contribute as much as 50% of the total O. D.
of normal sera (15).
Purity of adenosine deaminase
Reference (10) indulges in prolonged speculative
calculations and theorises on the effect that the con-
tamination of commercial adenosine deaminase by
AMP deaminase might have on the various methods.
Our experiments on this point are presented in Table 1
which shows that when adenosine deaminase is used
in 16-fold excess over the amount we normally employ,
an apparent increase in S'-nucleotidase activity equi-
valent to 3 IU// would be obtained if /?-glycerophos~
phate were omitted. This shows that the contaminating
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Fig, 2
Hydrolysis of 5'-AMP in absence and presence of various concen-
trations of disodium phenyl phosphate by fresh dialysed human bile
diluted in glycerol (alkaline phosphatase activity 331 King Units per
100 ml), calf intestinal alkaline phosphatase from Boehringer Corpo-
ration (London) Ltd., Cat. No. 15436 EPAC, dialysed free of ammonia(activity 48 King Units per 100 mi), and a butanol preparation of
human bone essentially according to MORTON (20) activity 150 King
Units per 100 ml). (>- ·^) no phenylphosphate; (^—^) 8 HIM, (·—·)
25 mM phenylphosphate; (o—o) constant ratio 5'-AMP: phenylphos-
phate of 5:8 mM. 100 μΐ of each preparation used under reaction
conditions of PERSIJN (7—10) with colour development of same author
and enzyme incubation time 30 min. Alkaline phosphatase activity
determined by method of KIND and KING (19).
JE = Etest—Ebiank
enzyme in commerical adenosine deaminase prepa-
rations, previously thought to be AMP deaminase (7),
is more probably a non-specific phosphatase, and is
inhibited by the -glycerophosphate which has been
an integral part of all our S'-nucleotidase assays utilising
adenosine deaminase. In any case, the pH optimum of
AMP deaminase, is 5.9 (16), which is far removed from
pH 7.9 at which our assay is conducted; and we have
always recommended a system of reagent checks with
each batch of determinations (3, 4).
pH of Assay
PERSIJN and colleagues employ a buffer at pH 7.5 in
their assay. They have not published a pH-activity
curve using their method. We have shown, with two
methods, that the pH optimum for serum S'-nucleo-
tidase is 7.9 (1, 4) and our assays are conducted at this
pH.
Precision
The authors of reference (10) complain that we have
not stated the precision of our spectrophotometric
method in the normal range. Previously (2) we gave an
estimate of precision based upon replicate analyses of
a serum with moderately raised activity. The precision
of this method in the normal range was evaluated by
calculating the standard deviation of pooled duplicates
according to PEARSON (17) using the data routinely
accumulated in our laboratory, the value being 1.9 IU//.
This approximates to more than twice the variance
claimed by the authors of reference (7) who have not,
however, given this information for their most recent
modification (9).
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Sensitivity
Reference (10) Table 3 gives a misleading impression
of the relative sensitivities of our spectrophotometric
method (2) and that of the former authors. When the
data are expressed as theoretical O. D. change per hour
per ml of serum, the spectrophotometric methods
(2, 14) are 50% more sensitive than the colorimetric
method of PERSIJN (7). Our own colorimetric method
is, using the same criteria, the most sensitive yet de-
scribed (4), but requires correction for inhibition of
the BERTHELOT reaction caused by the synergistic
action of serum and EDTA. PERSIJN and colleagues
have not satisfactorily met our criticism that they have
failed to recognise this inhibition. Until now, they
have presented data for the recovery of adenosine (7)
which averaged 98.1% (standard deviation 5.1%), and
made inferences based upon linearity between serum
volume and O. D. (10, Fig. 1) and EDTA concentration
(10, Fig. 2). In none of this work is it clearly stated
whether ammonia standards were employed. Using
their method exactly as published (7—9), we found a
consistent difference averaging 5% between the O. D.
generated by aqueous ammonia in the presence and
absence of 100 μΐ serum (Fig. 3) after making allowance
for the ammonia content of the serum. This is additional
to the inhibition due to veronal and EDTA, amounting
to approximately 5%, but allowed for by the device of
preparing adenosine standards in veronal and in-
cluding EDTA during colour development. With a
fixed concentration of ammonia, increasing the volume
of serum in the reaction mixture causes a linear de-
crease in O. D. (Fig. 4); this line was derived statisti-
cally from a least-squares fit, and the inhibition with
100 μΐ serum was 4.5%. This is much less than the
inhibition of about 15% occurring in our method (4).
Since we use the concentrated reagents of CHANEY
and MARBACH (16) whereas PERSIJN and colleagues use
these reagents in the dilute form, the concentration of
EDTA and serum and therefore the extent of inhi-
bition is greater in our system, but at the same time
sensitivity is also increased.
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Fig. 3
Absorbance at 625 nm of (NH4)tSO4 solutions measured by method
of PERSIJN (7) in presence (broken line) and absence (dotted line) of
100 μΐ pooled human serum. Final volume of reaction mixture, which
included buffer and Mg++, maintained constant
0,3, 50 100
serum [
150 200
Fig. 4
Absorbance at 625 nm of 0,125 /umoles (NH4)3SO4 measured by
method of PERSIJN (7) in presence of buffer and Mg-n- but varying
volume of pooled human serum, with total volume of reaction mixture
maintained constant
Tissue Specificity
In Fig. 2 human hepatic S'-nucleotidase, present in the
bile, shows, under the conditions of PERSIJN (7—10),
little increase in activity with increase in 5'-AMP
concentration. Hydrolysis of 5'-AMP is constant when
the molar ratio of 5'-AMP to phenyl phosphate is held
constant at 5:8. When phenyl phosphate is held con-
stant at 8 mM, increased hydrolysis of 5'-AMP occurs
with increasing concentration of the latter since the
alteration in the ratio favours its hydrolysis by non-
specific alkaline phosphatase. The two lines meet when
the absolute concentrations of phenyl phosphate and
5;-AMP are 8 mM and 5 mM respectively. The hydro-
lysis of 5'-AMP in the presence of 25 mM phenyl
phosphate is less than in the previous two cases, is less
susceptible to changes in 5'-AMP concentration fa-
vouring hydrolysis of the latter by alkaline phospha-
tase, and thus provides a more accurate measure of true
5'-nucleotidase activity. The results for the intestinal
and bone preparations lead to a similar interpretation.
It will however be apparent that these preparations
differ in the ratio of true 5'-nucleotidase to alkaline
phosphatase present in the material; in the affinity of
its alkaline phosphatase for 5'-AMP (intestinal phos-
phatase having the highest affinity); and in the sus-
ceptibility of its alkaline phosphatase to phenyl phos-
phate — induced suppression of 5'-AMP hydrolysis
(bone phosphatase being least susceptible). This last
point accords with the previously-documented re-
sistance of human bone phosphatase to -glycero-
phosphate-induced suppression of 5'-AMP hydrolysis
(5).
Conclusions
In our view, the spectrophotometric assay at 265 nm
(2) is the most specific method currently available. The
spectrophotometric assay at 340 nm (3) is less sensitive,
and the reagents are more expensive, but it is poten-
tially capable of adaptation to automatic analysis. The
method described by us (4) is the most sensitive colo-
rimetric procedure and is very suitable for paediatric
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work, but a substantial correction for colour inhibition
is needed. The method of PERSIJN and colleagues
(7—10) requires a much smaller correction for colour
inhibition, and in practise this could virtually be ignored,
but it employs five times as much serum and is not well
suited to paediatric work. It could be very useful in
adult work if the authors would modify their concen-
trations of true and alternative substrates in accordance
with the advice we have offered.
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